一般演題1-13B 移植前治療（2）

[OS1-13B-4] Impact of cytoreduction strategy and prognostic mutation on post-transplantation outcome in AML-MRC

Feng-Ming Tien^1,2, Cheng-Hong Tsai^1,2, Chien-Yuan Chen¹, Hsin-An Hou¹, Xiu-Wen Liao², Wen-Chien Chou¹, Hwei-Feng Tien¹, Jih-Luh Tang^1,2 (1.Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, 2.TaiCheng Stem Cell Therapy Center, National Taiwan University, Taipei, Taiwan)